Schedule 13G ownership disclosure

Vor BioPharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 929033207

Event date: 2025-12-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 2,258,001.00 · Class: 5.8%

  • FHMLSP, L.P.

    Shares: 2,258,001.00 · Class: 5.8%

  • FHMLSP, L.L.C.

    Shares: 2,258,001.00 · Class: 5.8%

  • Frazier Life Sciences XI, L.P.

    Shares: 21,114.00 · Class: 0.1%

  • FHMLS XI, L.P.

    Shares: 21,114.00 · Class: 0.1%

  • FHMLS XI, L.L.C.

    Shares: 21,114.00 · Class: 0.1%

  • Frazier Life Sciences XII, L.P.

    Shares: 264,824.00 · Class: 0.7%

  • FHMLS XII, L.P.

    Shares: 264,824.00 · Class: 0.7%

  • FHMLS XII, L.L.C.

    Shares: 264,824.00 · Class: 0.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-25-000641
Form type
SCHEDULE 13G
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Dec 19, 2025
Reporting period
Dec 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub